• Open an account Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c

Home   >  Equity   >  Get Quotes

  • SENSEX Jul 24 2019 02:30
    37,835.08 -147.66 (-0.39%)
  • NIFTY Jul 24 2019 02:34
    11,273.15 -57.90 (-0.51%)
  • SENSEX Jul 24 2019 02:30
    37,835.08 -147.66 (-0.39%)
  • NIFTY Jul 24 2019 02:34
    11,273.15 -57.90 (-0.51%)
  • Nasdaq Jul 24 2019 04:30
    8,251.40 +47.26 ( +0.58%)
  • DJIA Jul 24 2019 04:30
    27,349.19 +177.29 ( +0.65%)
  • S&P 500 Jul 24 2019 04:30
    3,005.47 +20.44 ( +0.68%)
  • Hang Seng Jul 23 2019 02:10
    28,466.48 +95.22 ( +0.34%)
  • Crude Oil Jul 24 2019 02:29
    3,947.00 +31.00 ( +0.79%)
  • Gold Jul 24 2019 02:29
    35,017.00 -4.00 (-0.01%)
  • Silver Jul 24 2019 02:29
    41,534.00 +100.00 ( +0.24%)
  • Copper Jul 24 2019 02:29
    451.80 +0.60 ( +0.13%)
  • Pound / Rupee Dec 23 2016 22:30
    85.91 +0.01 ( +0.01%)
  • Dollar / Rupee Dec 23 2016 22:30
    68.82 +0.08 ( +0.12%)
  • Euro / Rupee Dec 23 2016 22:30
    77.18 +0.07 ( +0.09%)
  • Yen / Rupee Dec 23 2016 22:30
    0.64 0.00 (0.00%)

Dr Lal Pathlabs Ltd

BSE Code : 539524 | NSE Symbol : LALPATHLAB | ISIN:INE600L01024| SECTOR: - |

NSE BSE
 

1,096.40

-3.10 (-0.28%) Volume 280564

24-Jul-2019 14:24:57

Prev. Close

1,099.50

Open Price

1,097.95

Bid Price (QTY)

1,095.30(7)

Offer Price (QTY)

1,096.40(3)

 

Today’s High/Low 1,108.00 - 1,108.00

52 wk High/Low 1,178.10 - 813.45

Key Stats

MARKET CAP (RS CR) 9158.41
P/E 46.88
BOOK VALUE (RS) 115.0205294
DIV (%) 60
MARKET LOT 1
EPS (TTM) 23.44
PRICE/BOOK 9.5539466365906
DIV YIELD.(%) 0.54
FACE VALUE (RS) 10
DELIVERABLES (%) 27.86

News & Announcements

16-Jul-2019

Dr Lal Pathlabs Ltd - Dr. Lal Path Labs Ltd. - Updates

11-Jul-2019

Dr Lal Pathlabs Ltd - Dr. Lal Path Labs Ltd. - Shareholders meeting

08-Jul-2019

Yes Bank Ltd leads gainers in 'A' group

08-Jul-2019

Dr. Lal PathLabs jumps about 8% in four sessions

18-May-2019

Board of Dr. Lal PathLabs recommends final dividend

17-May-2019

Board of Dr Lal Pathlabs appoints director

23-Apr-2019

Dr. Lal PathLabs announces board meeting date

17-Jan-2019

Dr. Lal PathLabs to hold board meeting

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Advanced Micronic Devices Ltd 517552
Apollo Hospitals Enterprise Ltd 508869 APOLLOHOSP
Artemis Global Life Sciences Ltd 540616 AGLSL
Aspira Pathlab & Diagnostics Ltd 540788
Aster DM Healthcare Ltd 540975 ASTERDM
Casil Health Products Ltd(merged) 523254
CDR Health Care Ltd 523353
Centenial Surgical Suture Ltd 531380
Chennai Meenakshi Multispeciality Hospital Ltd 523489
Cure Spects Laser Ltd 531356
Datt Mediproducts Ltd 532171 DATTMEDI
Deccan Hospital Corporation Ltd (Merged) 523258
Dhanvantri Jeevan Rekha Ltd 531043
Digiflex India Ltd 526111
Disposable Medi - Aids Ltd 523540
Dolphin Medical Services Ltd 526504
Dr Agarwals Eye Hospital Ltd 526783
Dr Lalchandani Labs Ltd 541299
Emaai Pharma Ltd 524756
Fidelity Industries Ltd (Wound-up) 526425
Fortis Healthcare Ltd 532843 FORTIS
Fortis Malar Hospitals Ltd 523696
Gil Hospitals Ltd (Wound-up) 526063
Healthcare Global Enterprises Ltd 539787 HCG
Indraprastha Medical Corporation Ltd 532150 INDRAMEDCO
Invicta Meditek Ltd 523844
Iswar Medical Services Ltd 507480 ISWARMEDIC
Kemwell International Ltd 530827
Keshlata Cancer Hospital Ltd 40450
Kids Medical Systems Ltd 540812
KMC Speciality Hospitals (India) Ltd 524520
Kovai Medical Center & Hospital Ltd 523323 KOVAI
La Medical Devices Ltd (Wound-up) 524772
Lifeline Injects Ltd 523379
Lokmanya Industries Ltd 526421
Looks Health Services Ltd 534422
Lotus Eye Hospital & Institute Ltd 532998 LOTUSEYE
Maestros Mediline Systems Ltd 501209
Medinova Diagnostic Services Ltd 526301
Metropolis Healthcare Ltd 542650 METROPOLIS
Monozyme India Ltd 522199
N G Industries Ltd 530897
Narayana Hrudayalaya Ltd 539551 NH
New World Medical (India) Ltd 524496
Noida Medicare Centre Ltd 523670
Nova Surgikos Ltd 524762
Opto Circuits (India) Ltd 532391 OPTOCIRCUI
Pramila Kidney Hospitals Ltd 40265
Raaj Medisafe India Ltd 524502
Regency Hospital Ltd 526403
Safire Global Medicare Ltd 524418 CDRMEDICAL
Sangam Health Care Products Ltd 531625
Secunderabad Healthcare Ltd 524540
Shalby Ltd 540797 SHALBY
Sharma East India Hosp and Medical Research Ltd 524548
Shiva Medicare Ltd 524602
Shree Pacetronix Ltd 527005
Siemens Healthcare Diagnostics Ltd(merged) 506559
Soni Medicare Ltd 539378
Span Divergent Ltd 524727
Sterling (Gujarat) Hospitals Ltd 531741
Surgiplast Ltd 523077
Surlux Diagnostic Ltd 507854
Surlux Health Centres Ltd 523265
Surlux Mediquip Ltd 523515
Tamilnad Hospital Ltd 523443
Tejnaksh Healthcare Ltd 539428
Thyrocare Technologies Ltd 539871 THYROCARE
Transgene Biotek Ltd 526139
Transmedica (India) Ltd 526461
Twenty First Century Medicare Ltd 40212
United Diagnostic International Ltd 523485

Share Holding

Category No. of shares Percentage
Total Foreign 22023144 26.43
Total Institutions 7686614 9.22
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 976688 1.17
Total Promoters 47431898 56.91
Total Public & others 5223266 6.27
Total 83341610 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr. Lal PathLabs has built a national, 'hub and spoke' network that includes its National Reference Laboratory in New Delhi, Regional Reference Lab in Kolkata and 191 other clinical laboratories, 2153 patient service centers and 5,624 pickup points as of March 31, 2018. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The catalogue of services includes 1,110 test panels, 2,028 pathology tests and 1,561 radiology and cardiology tests. Late Dr. Major S.K. Lal, commenced the business of providing pathology services and maintaining a blood bank in the year 1949 through sole proprietorship M/s Central Clinical Laboratory and M/s Blood Bank Transfusion Centre. The business of diagnostic and related healthcare tests and services now continues to be provided by the Company 'Dr Lal Pathlabs Pvt Ltd' The Company was incorporated as Dr. Lal PathLabs Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation granted by the RoC on February 14, 1995 at Delhi. The business of the partnership firm Central Clinical Laboratory is now undertaken by the Company, while Central Clinical Laboratory does not undertake any business operations. The Company was converted into a public company pursuant to a special resolution of the shareholders of our Company at an EGM held on August 7, 2015. Consequently, the name of our Company was changed to Dr. Lal PathLabs Limited' and a fresh certificate of incorporation pursuant to the change of name was granted by the RoC on August 19, 2015. The Board of Directors of Dr. Lal PathLabs at its meeting held on 27 May 2016 approved acquisition of M/s Delta Ria and Pathology Private Limited. The Board also approved the acquisition of additional 10% stake each in Dr. Lal PathLabs' subsidiaries M/s Paliwal Diagnostics Private Limited (PDPL) and Paliwal Medicare Private Limited. The Board of Directors of Dr. Lal PathLabs at its meeting held on 12 May 2017 approved the Scheme of Amalgamation of Delta Ria and Pathology Private Limited, a wholly owned subsidiary of the company with the company with effect from 1 April 2017. The Board of Directors of Dr. Lal PathLabs at its meeting held on 7 August 2017 approved acquisition of 70% stake in Dr. Lal Path Labs Bangladesh (Pvt) Limited (DLPLB) from existing shareholders. Prior to investment in the company by Dr. Lal PathLabs, DLPLB shall be acquiring the running diagnostic business of a sole-proprietorship firm in Dhaka, Bangladesh. On 12 December 2017, Dr. Lal PathLabs announced that the Board of Directors of the company's subsidiary Paliwal Diagnostics Private Limited, at its meeting held on 12 December 2017 approved acquisition of a proprietary concern viz. Satya Pathology and Diagnostic Centre (SPDC) based out of Kanpur. SPDC clocked turnover of Rs 1.46 crore in FY 2017. Dr. Lal PathLabs' Kolkata Reference Lab started testing of samples in early January 2018. The World-class Lab will cater the demand from Northeast as well as Eastern regions of India. It will also cater to neighboring international

Contact us